Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study to Evaluate the Immunogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older

NCT05415462 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT05415462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05415462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study to Evaluate the Immunogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older
Lead sponsor
ModernaTX, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2022
Completion date
September 4, 2023
Enrollment
6,102 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal influenza